Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy

Taro Matsui; Yukihiro Hamada; Motoi Kuwahara; Jyoji Morise; Shogo Oka; Kenichi Kaida; Susumu Kusunoki

doi:10.1016/j.jneuroim.2019.577127

Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy

Taro Matsui
, Yukihiro Hamada
, Motoi Kuwahara
, Jyoji Morise
, Shogo Oka
, Kenichi Kaida
, Susumu Kusunoki

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Anti-myelin-associated glycoprotein (MAG) neuropathy is mediated by the binding of IgM M-proteins to the human natural killer-1 epitope of several glycoconjugates, including MAG and phosphacan. We recently reported that IgM M-proteins with a higher ratio of anti-phosphacan titer to anti-MAG titer (P/M ratio) were associated with a progressive clinical course. Herein, we investigated the temporal variability of the P/M ratio. The results showed that P/M ratios in worsened cases were significantly increased relative to stable or improved cases. Thus, temporal variability in the specificity of IgM M-proteins may be related to the disease course of anti-MAG neuropathy.

Original language	English
Article number	577127
Journal	Journal of Neuroimmunology
Volume	339
DOIs	https://doi.org/10.1016/j.jneuroim.2019.577127
Publication status	Published - 15-02-2020
Externally published	Yes

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Neurology
Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jneuroim.2019.577127

Cite this

@article{d07b937e7a7d485c892abeaf531bd9d3,

title = "Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy",

abstract = "Anti-myelin-associated glycoprotein (MAG) neuropathy is mediated by the binding of IgM M-proteins to the human natural killer-1 epitope of several glycoconjugates, including MAG and phosphacan. We recently reported that IgM M-proteins with a higher ratio of anti-phosphacan titer to anti-MAG titer (P/M ratio) were associated with a progressive clinical course. Herein, we investigated the temporal variability of the P/M ratio. The results showed that P/M ratios in worsened cases were significantly increased relative to stable or improved cases. Thus, temporal variability in the specificity of IgM M-proteins may be related to the disease course of anti-MAG neuropathy.",

keywords = "Anti-MAG neuropathy, MAG, P/M ratio, Phosphacan, Prognosis",

author = "Taro Matsui and Yukihiro Hamada and Motoi Kuwahara and Jyoji Morise and Shogo Oka and Kenichi Kaida and Susumu Kusunoki",

note = "Publisher Copyright: {\textcopyright} 2019",

year = "2020",

month = feb,

day = "15",

doi = "10.1016/j.jneuroim.2019.577127",

language = "English",

volume = "339",

journal = "Journal of Neuroimmunology",

issn = "0165-5728",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy

AU - Matsui, Taro

AU - Hamada, Yukihiro

AU - Kuwahara, Motoi

AU - Morise, Jyoji

AU - Oka, Shogo

AU - Kaida, Kenichi

AU - Kusunoki, Susumu

PY - 2020/2/15

Y1 - 2020/2/15

N2 - Anti-myelin-associated glycoprotein (MAG) neuropathy is mediated by the binding of IgM M-proteins to the human natural killer-1 epitope of several glycoconjugates, including MAG and phosphacan. We recently reported that IgM M-proteins with a higher ratio of anti-phosphacan titer to anti-MAG titer (P/M ratio) were associated with a progressive clinical course. Herein, we investigated the temporal variability of the P/M ratio. The results showed that P/M ratios in worsened cases were significantly increased relative to stable or improved cases. Thus, temporal variability in the specificity of IgM M-proteins may be related to the disease course of anti-MAG neuropathy.

AB - Anti-myelin-associated glycoprotein (MAG) neuropathy is mediated by the binding of IgM M-proteins to the human natural killer-1 epitope of several glycoconjugates, including MAG and phosphacan. We recently reported that IgM M-proteins with a higher ratio of anti-phosphacan titer to anti-MAG titer (P/M ratio) were associated with a progressive clinical course. Herein, we investigated the temporal variability of the P/M ratio. The results showed that P/M ratios in worsened cases were significantly increased relative to stable or improved cases. Thus, temporal variability in the specificity of IgM M-proteins may be related to the disease course of anti-MAG neuropathy.

KW - Anti-MAG neuropathy

KW - MAG

KW - P/M ratio

KW - Phosphacan

KW - Prognosis

UR - https://www.scopus.com/pages/publications/85076237300

UR - https://www.scopus.com/pages/publications/85076237300#tab=citedBy

U2 - 10.1016/j.jneuroim.2019.577127

DO - 10.1016/j.jneuroim.2019.577127

M3 - Article

C2 - 31841738

AN - SCOPUS:85076237300

SN - 0165-5728

VL - 339

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

M1 - 577127

ER -

Association of variability in antibody binding affinity with a clinical course of anti-MAG neuropathy

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this